These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
737 related items for PubMed ID: 27451857
1. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase. Jung IP, Ha NR, Lee SC, Ryoo SW, Yoon MY. Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857 [Abstract] [Full Text] [Related]
2. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase. Baig IA, Moon JY, Lee SC, Ryoo SW, Yoon MY. Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243 [Abstract] [Full Text] [Related]
3. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase. Lu W, Baig IA, Sun HJ, Cui CJ, Guo R, Jung IP, Wang D, Dong M, Yoon MY, Wang JG. Eur J Med Chem; 2015 Apr 13; 94():298-305. PubMed ID: 25771108 [Abstract] [Full Text] [Related]
4. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay. Wang D, Zhu X, Cui C, Dong M, Jiang H, Li Z, Liu Z, Zhu W, Wang JG. J Chem Inf Model; 2013 Feb 25; 53(2):343-53. PubMed ID: 23316686 [Abstract] [Full Text] [Related]
5. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y, Zhou S, Deng Q, Li X, Meng J, Guan Y, Li C, Xiao C. Tuberculosis (Edinb); 2016 Mar 25; 97():38-46. PubMed ID: 26980494 [Abstract] [Full Text] [Related]
6. Cloning, characterization and evaluation of potent inhibitors of Shigella sonnei acetohydroxyacid synthase catalytic subunit. Lim WM, Baig IJ, La IJ, Choi JD, Kim DE, Kim SK, Hyun JW, Kim G, Kang CH, Kim YJ, Yoon MY. Biochim Biophys Acta; 2011 Dec 25; 1814(12):1825-31. PubMed ID: 22015678 [Abstract] [Full Text] [Related]
15. In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of Mycobacterium tuberculosis isolated from a hospital in Beijing, China. Dong M, Wang D, Jiang Y, Zhao L, Yang C, Wu C. Saudi Med J; 2011 Nov 25; 32(11):1122-6. PubMed ID: 22057598 [Abstract] [Full Text] [Related]
16. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. Naz S, Farooq U, Ali S, Sarwar R, Khan S, Abagyan R. J Biomol Struct Dyn; 2019 Mar 25; 37(4):1043-1053. PubMed ID: 29502488 [Abstract] [Full Text] [Related]
17. Mechanisms of bacterial acetohydroxyacid synthase (AHAS) and specific inhibitors of Mycobacterium tuberculosis AHAS as potential drug candidates against tuberculosis. Gokhale K, Tilak B. Curr Drug Targets; 2015 Mar 25; 16(7):689-99. PubMed ID: 25882218 [Abstract] [Full Text] [Related]